EUVIMEDEUVIMED entdecken
Crossref

Combined prenatal screening of trimester I of pregnancy as a prognostic marker of Great obstetrical syndromes development

N.Y. Lemish

UKRAINIAN JOURNAL HEALTH OF WOMAN · 2022

DOI: 10.15574/hw.2022.160.36 ↗

Kurz gefasst

Fachartikel in der Zeitschrift UKRAINIAN JOURNAL HEALTH OF WOMAN, 2022. Verfasst von N.Y. Lemish.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose - to conduct an analysis of the combined prenatal screening of the trimester I of pregnancy in women who had complications from the group of great obstetric syndromes. Materials and methods. A retrospective statistical analysis of the combined prenatal screening of the trimester I was carried out. Of the 239 pregnant women (Group I - main) who had complications from the group of great obstetric syndromes, according to the data of the pregnancy monitoring exchange cards, combined prenatal screening of the trimester I was carried out in 65.3% of pregnant women, which amounted to 156 pregnant women who were divided into three subgroups: Ia (n=74) pregnant women with severe preeclampsia, Ib (n=40) pregnant women with placental insufficiency, clinically verified fetal growth retardation; Ic (n=42) of pregnant women with spontaneous premature birth in the gestation period of 22-36 weeks. The control group (CG) was 56 practically healthy pregnant women with a healthy reproductive history and an uncomplicated course of this pregnancy. Statistical processing of the research results was carried out using standard Microsoft Excel 5.0 and Statistica 6.0 programs. Results. In the Group I, the average term of trimester I screening was 12 weeks 3±4 days, in the CG - 12 weeks 1±3 days, the difference in the gestational term of the trimester I combined screening was statistically insignificant. The lowest level of PAPP-A was determined in subgroups Ia and subgroup Ic. In the Group I, the level of PAPP-A was on average 2.16 (1.35-3.24) IU/l and 0.836 (0.571-1.14) MoM, and in CG - 2.62 (1.82-4, 12) MO/l and 1.16 (0.786-1.7) MoM. According to the relative number of patients with a level of PAPP-A

Zitieren

APA

Lemish, N. (2022). Combined prenatal screening of trimester I of pregnancy as a prognostic marker of Great obstetrical syndromes development. UKRAINIAN JOURNAL HEALTH OF WOMAN. https://doi.org/10.15574/hw.2022.160.36

Vancouver

Lemish N. Combined prenatal screening of trimester I of pregnancy as a prognostic marker of Great obstetrical syndromes development. UKRAINIAN JOURNAL HEALTH OF WOMAN. 2022. doi:10.15574/hw.2022.160.36

BibTeX
@article{Lemish2022,
  author = {Lemish, N.Y.},
  title = {Combined prenatal screening of trimester I of pregnancy as a prognostic marker of Great obstetrical syndromes development},
  journal = {UKRAINIAN JOURNAL HEALTH OF WOMAN},
  year = {2022},
  doi = {10.15574/hw.2022.160.36}
}
Kostenlos starten →